MA25509A1 - Composition destinee au traitement de l'hepatite c - Google Patents

Composition destinee au traitement de l'hepatite c

Info

Publication number: MA25509A1
Authority: MA; Morocco
Prior art keywords: hepatitis; treatment; composition
Prior art date: 2000-03-22

Application number

MA26657A

Other languages

English (en)

Inventor

Wassyl Nowicky

Original Assignee

Nowicky Wassili

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-22

Filing date

2002-05-28

Publication date

2002-07-01

2002-05-28 Application filed by Nowicky Wassili filed Critical Nowicky Wassili

2002-07-01 Publication of MA25509A1 publication Critical patent/MA25509A1/fr

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses

MA26657A 2000-03-22 2002-05-28 Composition destinee au traitement de l'hepatite c MA25509A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AT0048100A AT408719B (de)	2000-03-22	2000-03-22	Mittel zur behandlung von hepatitis c

Publications (1)

Publication Number	Publication Date
MA25509A1 true MA25509A1 (fr)	2002-07-01

Family

ID=3674939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA26657A MA25509A1 (fr)	2000-03-22	2002-05-28	Composition destinee au traitement de l'hepatite c

Country Status (17)

Country	Link
JP (1)	JP2003527414A (fr)
KR (1)	KR20020087045A (fr)
CN (1)	CN1416347A (fr)
AT (1)	AT408719B (fr)
AU (1)	AU2001239000A1 (fr)
BG (1)	BG107088A (fr)
BR (1)	BR0107211A (fr)
CA (1)	CA2389173A1 (fr)
EA (1)	EA200200584A1 (fr)
HR (1)	HRP20020367A2 (fr)
IL (1)	IL149314A0 (fr)
IS (1)	IS6360A (fr)
MA (1)	MA25509A1 (fr)
MX (1)	MXPA02004993A (fr)
NO (1)	NO20022253D0 (fr)
PL (1)	PL365000A1 (fr)
WO (1)	WO2001070203A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH695417A5 (de) *	2001-11-15	2006-05-15	Ddr Wassyl Nowicky Dipl Ing	Verfahren zur Umsetzung von Alkaloiden.
EP1459753A1 (fr)	2003-03-18	2004-09-22	Nowicky, Wassyl, Dipl.-Ing. DDr.	Dérivés quaternaires de chelidonine et d'alkaloides, procédé pour leur préparation et leur utilisation dans la préparation de médicaments
EP2083825A4 (fr) *	2006-09-26	2009-11-04	Addiction Res Inst Inc	Compositions de traitement de l'hépatite c et procédés d'utilisation des compositions de traitement de l'hépatite c
CN106343303A (zh) *	2015-07-13	2017-01-25	张如安	灭杀乙肝病毒的饮料
CN106109538A (zh) *	2016-07-29	2016-11-16	桂林淮安天然保健品开发有限公司	治疗丙肝的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3128018A1 (de) *	1981-07-13	1983-04-07	Wassyl 1060 Wien Nowicky	"verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4816462A (en) *	1982-05-18	1989-03-28	Nowicky Wassili	Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
US4970212A (en) *	1982-05-18	1990-11-13	Nowicky Wassili	Method of treating human illnesses which compromise the ability to mount an effective immunological response
PT93772A (pt) *	1989-04-17	1991-01-08	Searle & Co	Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer

2000
- 2000-03-22 AT AT0048100A patent/AT408719B/de not_active IP Right Cessation
2001
- 2001-03-20 JP JP2001568401A patent/JP2003527414A/ja active Pending
- 2001-03-20 EA EA200200584A patent/EA200200584A1/ru unknown
- 2001-03-20 AU AU2001239000A patent/AU2001239000A1/en not_active Abandoned
- 2001-03-20 IL IL14931401A patent/IL149314A0/xx unknown
- 2001-03-20 WO PCT/AT2001/000076 patent/WO2001070203A2/fr active Application Filing
- 2001-03-20 CN CN01803046A patent/CN1416347A/zh active Pending
- 2001-03-20 MX MXPA02004993A patent/MXPA02004993A/es unknown
- 2001-03-20 BR BR0107211-0A patent/BR0107211A/pt not_active IP Right Cessation
- 2001-03-20 CA CA002389173A patent/CA2389173A1/fr not_active Abandoned
- 2001-03-20 PL PL01365000A patent/PL365000A1/xx not_active Application Discontinuation
- 2001-03-20 KR KR1020027005739A patent/KR20020087045A/ko not_active Application Discontinuation
2002
- 2002-04-24 IS IS6360A patent/IS6360A/is unknown
- 2002-04-26 HR HR20020367A patent/HRP20020367A2/hr not_active Application Discontinuation
- 2002-05-10 NO NO20022253A patent/NO20022253D0/no unknown
- 2002-05-28 MA MA26657A patent/MA25509A1/fr unknown
- 2002-09-12 BG BG107088A patent/BG107088A/xx unknown

Also Published As

Publication number	Publication date
WO2001070203A2 (fr)	2001-09-27
CN1416347A (zh)	2003-05-07
AU2001239000A1 (en)	2001-10-03
IL149314A0 (en)	2002-11-10
ATA4812000A (de)	2001-07-15
BR0107211A (pt)	2004-01-06
EA200200584A1 (ru)	2003-06-26
NO20022253L (no)	2002-05-10
KR20020087045A (ko)	2002-11-21
JP2003527414A (ja)	2003-09-16
IS6360A (is)	2002-04-24
WO2001070203A3 (fr)	2002-09-06
PL365000A1 (en)	2004-12-27
BG107088A (en)	2003-05-30
NO20022253D0 (no)	2002-05-10
HRP20020367A2 (en)	2004-02-29
MXPA02004993A (es)	2003-10-14
CA2389173A1 (fr)	2001-09-27
AT408719B (de)	2002-02-25

Similar Documents

Publication	Publication Date	Title
FR07C0046I2 (fr)	2008-05-09	Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
FR20C1039I2 (fr)	2021-08-13	Derives de l'uk-2a
CY2018020I2 (el)	2019-07-10	Θεραπεια της νοσου ρομρε
MA27126A1 (fr)	2005-01-03	3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES
CH1143977H1 (fr)	2007-02-15	2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
EE200200716A (et)	2004-08-16	Ühendid Alzheimeri tõve käitluseks
MA26207A1 (fr)	2004-07-01	Compositions de traitement de l'eau.
MA25823A1 (fr)	2003-07-01	Compositions pour le traitement de l'eau.
ATE315938T1 (de)	2006-02-15	4'-substituierte nukleoside zur behandlung von hepatitis-c-virus-vermittelten erkrankungen
EE200300307A (et)	2003-10-15	1,5-bensotiasepiinid ja nende kasutamine antilipideemiliste vahenditena
NO2012018I2 (no)	2012-11-21	Canakinumab eller direkte ekvivalenter derav
DE69912223D1 (de)	2003-11-27	Methylmethacrylat-Zusammensetzung
DE60019158D1 (de)	2005-05-04	Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60123238D1 (de)	2006-11-02	Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE10082139T1 (de)	2001-10-04	Zusammensetzung zur Behandlung von Reibungspaaren
EE05020B1 (et)	2008-06-16	Glburiidi ravimkoostis
DE69841984D1 (de)	2010-12-16	Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen
DZ3014A1 (fr)	2004-03-27	Médicaments pour le traitement de l'hypertension.
EE200200632A (et)	2004-04-15	Glükokortikoidravimeid sisaldavad preparaadid bronhopulmonaalsete haiguste raviks
DE60008353D1 (de)	2004-03-25	Hemihydrat von 16.alpha.-bromoepiandrosterone
ID25765A (id)	2000-11-02	Komposisi pembersih kulit
FR2758465B1 (fr)	1999-04-09	Composition pour le traitement de l'amiante
FR2857597B1 (fr)	2008-01-25	Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l'alopecie.
MA25509A1 (fr)	2002-07-01	Composition destinee au traitement de l'hepatite c
DE69913380D1 (de)	2004-01-15	Zusammensetzung zur behandlung von periodontalen erkrankungen